Semnur Pharmaceuticals Overview

  • Founded
  • 2013
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 9
Employees
  • Latest Deal Type
  • M&A

Semnur Pharmaceuticals General Information

Description

Developer of non-opioid drugs designed for the treatment of lumbar radicular pain. The company's drugs focus on the clinical and commercial development of innovative products for meeting the needs of underserved patients with back pain, enabling pain management practitioners to improve products' efficacy and safety making a substantial improvement in the treatment of back pain.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 301 North Whisman Road
  • Suite 100
  • Mountain View, CA 94043
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Semnur Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 22-Mar-2019 000 Completed Generating Revenue
2. Merger/Acquisition 06-Oct-2017 00000 00000 Cancelled Generating Revenue
1. Early Stage VC (Series A) 15-Aug-2013 $6M $6M 000.00 Completed Startup
To view Semnur Pharmaceuticals’s complete valuation and funding history, request access »

Semnur Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view Semnur Pharmaceuticals’s complete cap table history, request access »

Semnur Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of non-opioid drugs designed for the treatment of lumbar radicular pain. The company's drugs focus on the clin
Drug Discovery
Mountain View, CA
9 As of 2016
000
000000&0 000

000000

henderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cup
0000 000000000
San Francisco, CA
0 As of 0000
0000
000000000000 0000

000000 0

minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Du
0000 000000000
Columbus, OH
0 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Semnur Pharmaceuticals Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Adynxx Formerly VC-backed San Francisco, CA 0 0000 000000000000 0000
000000 00000000000 Venture Capital-Backed Columbus, OH 0 000.00 0000000000 0 000.00
0000000000 0000000 Venture Capital-Backed Boston, MA 00 00000 00000000
0000000 Formerly VC-backed Emeryville, CA 000 00000 000000 - 000 00000
0000000000 Pending Transaction (Debt) Aachen, Germany 0000 00000 0000 00000
You’re viewing 5 of 15 competitors. Get the full list »

Semnur Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Semnur Pharmaceuticals Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Canaan Partners Venture Capital Minority 000 0000 000000 0
Frazier Healthcare Partners PE/Buyout Minority 000 0000 000000 0
Vivo Capital Venture Capital Minority 000 0000 000000 0
To view Semnur Pharmaceuticals’s complete investors history, request access »